MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Surface mechanised nano-formulation of naringenin as adenosine A2A receptor antagonist against in Neurological associated problem of Parkinson

    V. Kumar (Allahabad, India)

    Objective: In the current experimental study, we intended to develop Surface mechanized nano-formulation of naringenin (NG) as potent A(2A)AR antagonists against parkinson’s disease. Background: One…
  • 2018 International Congress

    What makes a successful Phase 2 study: An evaluation of Parkinson’s neuroprotective trial design over the last 5 years

    T. Dominey, S. Buff, G. Rafaloff, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate variation in Phase 2 and 3 Parkinson’s disease (PD) neuroprotective trial designs and identify key trial design features in Phase 2 studies…
  • 2018 International Congress

    Dual task in the daily life of patients with Parkinson’s disease

    K. Mejia (Lima, Peru)

    Objective: Determine which of the types of motor or cognitive tasks interfere most severely in the dual task in the daily life of patients with…
  • 2018 International Congress

    Efficacy and security starting safinamide treatment with 100 mg/day in PD

    N. Foncea (Galdakao, Spain)

    Objective: Evaluating the efficacy and security starting safinamide treatment with 100 mg/day in PD Background: Dopaminergic treatment has been useful in PD. Other neurotransmission mechanisms…
  • 2018 International Congress

    Impact on the Quality of Life (CV) of people with Parkinson’s disease participating in community workshops of the public health system of Coquimbo, Chile

    S. Stange, D. Mansilla, Y. Diaz, Y. Córdoba (Coquimbo, Chile)

    Objective: To show the Impact in the CV of the People with Parkinson's Disease through the permanent assistance to the multidisciplinary community workshops of their…
  • 2018 International Congress

    Double-blind controlled trial of Spectramax™ light therapy for the treatment of Parkinson’s disease patients on stable dopaminergic therapy

    A. Videnovic, S. Rutten, W. Croft, H. Erickson, J. Groves, C. Havemann, T. Herrington, S. Hendrix, K. Kieburtz, Y. vander Werf, O. vanden Heuvel (Boston, MA, USA)

    Objective: To evaluate the safety and effectiveness of Spectramax™ specialized bandwidth light therapy (LT) as adjunctive treatment in Parkinson’s disease (PD). Background: Previous studies have…
  • 2018 International Congress

    Deep brain stimulation matters in pediatric neurology – single-center experience

    M. Freilinger, A. Zeitlberger, S. Siegert, R. Seidl, F. Alesch, G. Kranz, K. Novak (Vienna, Austria)

    Objective: This study is to review our single-center experience with deep brain stimulation (DBS) in pediatric patients with dystonia. Background: Deep brain stimulation (DBS) is…
  • 2018 International Congress

    Movement disorder associated with 3-Idroxyisobutyryl-Coa hydrolase (HIBCH) deficiency

    F. Nardecchia, L. Pollini, C. Carducci, M. Tolve, S. De Leo, C. Carducci, V. Leuzzi (Rome, Italy)

    Objective: To describe an early onset movement disorder due to impairment of valine metabolism. Background: HIBCH deficiency is a rare inborn error of valine metabolism…
  • 2018 International Congress

    Neurologic Wilson’s Disease: Case Series on a Diagnostic and Therapeutic Emergency

    R. Porlas, L. De Castillo, C. Dioquino (Manila, Philippines)

    Objective: To present two cases of Neurologic Wilson's Disease with two different clinical picture. To review the the important diagnostics and tests in clinching the…
  • 2018 International Congress

    MRI-guided Focused Ultrasound thalamotomy for Multiple Sclerosis-associated tremor: A case report

    B. Fernández-Rodríguez, D. Urso, M. Monje, JA. Pineda-Pardo, M. del Álamo, R. Blazquez-Navarro, F. Hernández-Fernández, L. Vela, F. Alonso-Frech, R. Martínez-Fernández, J. Obeso (Móstoles, Spain)

    Objective: To describe the effect of VIM thalamotomy by MRI-guided Focused Ultrasound (MRIgFUS) on Multiple Sclerosis (MS) tremor in a single patient. Background: Tremor is…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley